Related Experiment Video
Updated: May 5, 2026

A Simplified Stepwise Approach to Echo Guidance during Percutaneous Mitral Valve Repair
Published on: October 16, 2021
Permanent pacemaker insertion after CoreValve transcatheter aortic valve implantation: incidence and contributing
M Z Khawaja1, R Rajani, A Cook
1UK CoreValve Collaborative, Sussex Cardiac Centre, Brighton & Sussex University Hospital Trust, Eastern Road, Brighton, East Sussex, BN2 5BE, UK.
Insights
A significant one-third of patients need a permanent pacemaker (PPM) after CoreValve transcatheter aortic valve implantation. Factors like heart block and balloon predilatation increase this risk.
Area of Science:
- Cardiology
- Interventional Cardiology
- Medical Devices
Background:
- Permanent pacemaker (PPM) requirement is a known complication following transcatheter aortic valve implantation (TAVI).
- Assessing the incidence and predictors of PPM post-CoreValve TAVI is crucial for patient management.
Purpose of the Study:
- To determine the incidence of PPM within 30 days of CoreValve implantation in the UK.
- To develop an anatomic and electrophysiological model predicting PPM need after TAVI.
Main Methods:
- Retrospective analysis of 270 patients undergoing CoreValve TAVI across 10 UK centers.
- Evaluation of baseline and post-procedure ECG parameters, including QRS duration and bundle branch block incidence.
- Multivariable analysis to identify independent predictors of PPM requirement.
Main Results:
- 33.3% of patients required a PPM within 30 days post-procedure.
- Significant increases in QRS duration (105 to 135 ms) and LBBB incidence (13% to 61%) were observed.
- Independent predictors for PPM included periprocedural AV block, balloon predilatation, larger prosthesis size, increased septal diameter, and prolonged QRS duration.
Conclusions:
- One-third of patients undergoing CoreValve TAVI require a PPM within 30 days.
- Periprocedural AV block, balloon predilatation, larger prosthesis, increased interventricular septum diameter, and prolonged QRS duration are associated with PPM need.
Background:
Permanent pacemaker (PPM) requirement is a recognized complication of transcatheter aortic valve implantation. We assessed the UK incidence of permanent pacing within 30 days of CoreValve implantation and formulated an anatomic and electrophysiological model.
Methods And Results:
Data from 270 patients at 10 centers in the United Kingdom were examined. Twenty-five patients (8%) had preexisting PPMs; 2 patients had incomplete data. The remaining 243 were 81.3±6.7 years of age; 50.6% were male. QRS duration increased from 105±23 to 135±29 milliseconds (P<0.01). Left bundle-branch block incidence was 13% at baseline and 61% after the procedure (P<0.001). Eighty-one patients (33.3%) required a PPM within 30 days. Rates of pacing according to preexisting ECG abnormalities were as follows: right bundle-branch block, 65.2%; left bundle-branch block, 43.75%; normal QRS, 27.6%. Among patients who required PPM implantation, the median time to insertion was 4.0 days (interquartile range, 2.0 to 7.75 days). Multivariable analysis revealed that periprocedural atrioventricular block (odds ratio, 6.29; 95% confidence interval, 3.55 to 11.15), balloon predilatation (odds ratio, 2.68; 95% confidence interval, 2.00 to 3.47), use of the larger (29 mm) CoreValve prosthesis (odds ratio, 2.50; 95% confidence interval, 1.22 to 5.11), interventricular septum diameter (odds ratio, 1.18; 95% confidence interval, 1.10 to 3.06), and prolonged QRS duration (odds ratio, 3.45; 95% confidence interval, 1.61 to 7.40) were independently associated with the need for PPM.
Conclusion:
One third of patients undergoing a CoreValve transcatheter aortic valve implantation procedure require a PPM within 30 days. Periprocedural atrioventricular block, balloon predilatation, use of the larger CoreValve prosthesis, increased interventricular septum diameter and prolonged QRS duration were associated with the need for PPM.
Related Concept Videos
Cardiac Catheterization I: Pre-Procedure Overview
Cardiac Catheterization II: Right Heart Catheterization
Cardiac Catheterization IV: Nursing Management
Mitral Valve Prolapse I: Introduction
Mitral Valve Prolapse II: Assessment and Management
Aortic Regurgitation III: Medical Management

